New York City Real Estate Coin (NYCREC), A Tokenized Real Estate Fund With Cashflow Dividends, Announces Regulation S ICO in Q4 2018
Read about NYCREC at www.nycrec.io
NEW YORK, Sept. 06, 2018 (GLOBE NEWSWIRE) -- New York City Real Estate Coin (NYCREC), a tokenized real estate fund that allows token holders to enjoy the benefits of fractional ownership of real estate in New York City, has just announced that its Regulation S* securities token offering (STO) will begin in Q4 2018.
What is New York City Real Estate Coin?
NYCREC is the world’s first tokenized real estate fund focused on New York City real estate with an institutional-quality real estate and financial management team at the helm. It aims to give NYCREC token holders the following benefits:
- Regular dividends from the cashflow of the properties in the NYCREC portfolio, distributed in the form of Ethereum (ETH) airdrops to token holders
- Managed portfolio of real estate with greater flexibility and diversification than a similar real estate investment trust (REIT), which is typically narrower in its scope of investments
- Lower expense fees than a similar real estate investment trust (REIT), leading to more pass-through profits for token holder
- Independent financial reports on progress of the project and its finances after the ICO is completed
- Increased accessibility to New York City real estate for the international community
The long-term vision of the project is to tokenize real estate in major gateway cities around the world and to build a dedicated, collateralized blockchain for asset-backed security token offerings.
The Team Behind New York City Real Estate Coin
The NYCREC has managed or invested over $15 billion in real estate projects in New York City and other major gateway cities worldwide over a 21-year career with a risk-adjusted, year-over-year internal rate of return of up to 25%.
The team is decorated with Wall Street investment professionals, including Chief Executive Officer Alain Oberrotman, former Worldwide Controller at McKinsey; Chief Blockchain Officer Neil Benedict, former Head of Product Development at BANKEX; Chief Operations Officer Paul Brownstein, who recently bought a $100mm NPL (Non-Performing Loan) portfolio; Charles Wyman, Chief Investment Officer and former Head of Global Credit Research at PIMCO; and Principal Steven Wasserman, Senior Advisor to a $4 billion NYC-based hedge fund. Advisors to the team include Leonard Seelig, Executive Director of BABB and Serg Gulko, CEO of XTRD.
*NYCREC Tokens will only be offered by New York City Real Estate Coin to non-US persons in compliance with the registration provided by Regulation D and Regulation S of the United States Securities Exchange Act.
NYCREC is a tokenized real estate fund for New York City real estate with lower expense fees and greater diversification than a similar real estate investment trust (REIT). NYCREC Token holders will have the ability to receive dividends from the cashflow of the NYCREC portfolio in the form of Ethereum (ETH) airdrops. The team has managed or invested over $15 billion in real estate over their careers, with up to a 25% year-over-year risk-adjusted internal rate of return.
Steven Wasserman, Principal email@example.com
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Despite increasing trade tensions business confidence in Asia Pacific remains high15.11.2018 00:00 | Pressemelding
A net 51% of business leaders plan to raise investment levels Vietnam and China top targets for cross-border investment Majority of business leaders creating more jobs as a result of technology 65% call on governments to do more to develop STEM skills Rising concerns about moving data across borders PORT MORESBY, Papua New Guinea, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Business leaders across Asia Pacific remain confident that their companies revenues will grow over the next 12 months despite increasing trade frictions. In its latest survey of 1189 business leaders across the 21 Asia-Pacific Economic Cooperation (APEC) economies, PwC found that 35% were very confident of revenue growth, down slightly from 37% a year ago, while a net 51% plan to increase investments over the next year. PwC carried out the survey in the lead up to the APEC CEO Summit which takes place this week in Port Moresby, the capital of Papua New Guinea. Business leaders in the United States and Thailand were among the
Wencor Group Announces Acquisition of Silver Wings14.11.2018 15:58 | Pressemelding
Peachtree City, GA, Nov. 14, 2018 (GLOBE NEWSWIRE) -- WENCOR GROUP ANNOUNCES ACQUISITION OF SILVER WINGS Peachtree City, GA (November 8th, 2018) -- Wencor Group (“Wencor”), a leading solutions provider to the aerospace aftermarket, today announced the acquisition of Silver Wings Aerospace, a certified 145 repair station specializing in electric power and hydraulic component repair with unique capabilities in Used Serviceable Material (“USM”). Terms of the transaction were not disclosed. "We are pleased to welcome Silver Wings leadership and their employees to the Wencor team. This partnership aligns with our strategy to drive ATA chapter depth and proprietary component repair capabilities while enhancing our presence in USM. We are thrilled to partner with great entrepreneurs like Eddie Montalvo and Sean Beaubien and look forward to working with the rest of their team who have developed a high quality customer-focused MRO business" said Chris Curtis, Chief Executive Officer of Wencor G
Biome Grow subsidiary, Highland Grow, receives license to sell to other licensed producers from Health Canada14.11.2018 14:00 | Pressemelding
TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Biome Grow Inc. (“Biome” or the “Company”) (CSE:BIO) (Frankfurt:6OTA) is pleased to announce its Nova Scotia-based subsidiary, Highland Grow Inc. (“Highland Grow”), has received its license to sell to other licensed producers from Health Canada in accordance with subsection 11(5) of the Cannabis Regulations. "This license gives the company additional commercial sales avenues and flexibility for our high quality cannabis products and services that are ready for our customers," said Khurram Malik, CEO of Biome. The Health Canada license, issued in accordance with the Cannabis Act and Cannabis Regulations, specifically grants Highland Grow the ability to: possess cannabis; obtain dried cannabis, fresh cannabis, cannabis plants or cannabis plant seeds by cultivating, propagating, and harvesting cannabis; and, to sell cannabis in accordance with subsection 11(5) of the Cannabis Regulations. With this license, Highland Grow is positioned to sell and
Kofax Advances Enterprise-Wide Deployment of Next-Generation Robotic Process Automation to Rapidly and Exponentially Scale the Digital Workforce14.11.2018 14:00 | Pressemelding
Kofax RPA Powers Industry’s First Single-Vendor Intelligent Automation Offering; Free 12-Month Trial Provides Time to Build, Deploy and Measure Results with No Commitment IRVINE, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Kofax ®, a leading supplier of Intelligent Automation software to automate and digitally transform end-to-end business processes, today announced Kofax RPA’s next-generation robotic process automation (RPA) capabilities that leverage artificial intelligence (AI) and machine learning (ML). Providing “out-of-the-box” functionality, Kofax is first to market with a comprehensive, single-vendor, single-platform, Intelligent Automation solution. “Early adopters of RPA have experienced the many benefits in shifting human labor from ‘data gatherer’ to ‘data user’ roles. Increased productivity helps them remain on track for profitable growth, improved customer service and significant competitive advantage,” said Reynolds C. Bish, Chief Executive Officer of Kofax. “These excepti
Colliers International Expands in South Florida14.11.2018 13:30 | Pressemelding
Acquisition of Preeminent Brokerage and Management Firm Strengthens Leadership and Service Offering TORONTO and MIAMI, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Leading global commercial real estate services and investment management firm Colliers International Group Inc. (NASDAQ and TSX: CIGI) today announced the acquisition of Continental Real Estate Companies Commercial Properties Corp. (“CREC”), a market-leading commercial real estate services firm specializing in property management, project management and sales and lease brokerage. Founded in 1989 by Warren Weiser and Carol Greenberg Brooks, this acquisition brings an extensive portfolio of more than 12.6 million square feet of office, industrial and retail space in Florida and more than 100 professionals operating from three offices throughout the state to Colliers. Terms of the transaction were not disclosed. “This strategic acquisition positions Colliers as the top management and retail brokerage firm in the vibrant South Florida mark
ADC Therapeutics Announces Presentations at 60th American Society of Hematology (ASH) Annual Meeting14.11.2018 13:30 | Pressemelding
New clinical data highlight potential of novel pyrrolobenzodiazepine-based antibody drug conjugates for the treatment of relapsed or refractory lymphomas LAUSANNE, Switzerland, Nov. 14, 2018 (GLOBE NEWSWIRE) -- ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today announced that data from Phase I clinical trials of ADCT-402 (loncastuximab tesirine) and ADCT-301 (camidanlumab tesirine) have been selected for oral and poster presentations at the 60th American Society of Hematology (ASH) Annual Meeting, which is being held December 1-4 in San Diego. Jay Feingold, MD, PhD, Chief Medical Officer and Senior Vice President of Clinical Development at ADC Therapeutics, said, “We look forward to sharing updated data from our first-in-human clinical trials of ADCT-402 and ADCT-301 in multiple subtypes of lymphoma at the 2018 ASH Annual Meeting. Interim data show that ADCT-402, which targets CD
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom